Inventor · disambiguated record
Marco Thomann
Also filed as: THOMANN MARCO
7 granted patents·6 pending applications·21 citations·filing 2015–2023
78Inventor score
Files withHOFFMANN LA ROCHE7ROCHE DIAGNOSTICS OPERATIONS INC4GENENTECH INC1ROCHE DIAGNOSTICS OPERATIONS1
Top patents by PatentIndex Score
13 records- 0192US9809835B2Quantitative control of sialylationROCHE DIAGNOSTICS OPERATIONS INC·Filed 2015·Granted Nov 7, 2017·9 cites·8 claims
- 0290US11078511B2Aqueous compositionROCHE DIAGNOSTICS OPERATIONS INC·Filed 2017·Granted Aug 3, 2021·5 cites·1 claims
- 0385US9481902B2Quantitative control of sialylation and specific mono-sialylationROCHE DIAGNOSTICS OPERATIONS INC·Filed 2015·Granted Nov 1, 2016·7 cites·12 claims
- 0467US11788108B2CMP-dependent sialidase activityROCHE DIAGNOSTICS OPERATIONS INC·Filed 2021·Granted Oct 17, 2023·0 cites·7 claims
- 0565US2024101643A1In vitro glycoengineering of antibodiesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0657US11718653B2Method for in vitro glycoengineering of an erythropoiesis stimulating proteinHOFFMANN LA ROCHE·Filed 2020·Granted Aug 8, 2023·0 cites·9 claims
- 0755US2020325245A1Galactoengineered immunoglobulin 1 antibodiesGENENTECH INC·Filed 2020·Application pending·0 cites
- 0854US2020165320A1In vitro glycoengineering of antibodiesHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 0952US2020148735A1Method for in vitro glycoengineering of an erythropoiesis stimulating proteinHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 1047US11767342B2Method for in vitro glycoengineering of antibodiesHOFFMANN LA ROCHE·Filed 2019·Granted Sep 26, 2023·0 cites·18 claims
- 1143US12269867B2Re-use of enzymes in in vitro glycoengineering of antibodiesHOFFMANN LA ROCHE·Filed 2019·Granted Apr 8, 2025·0 cites·19 claims
- 1242US2017253661A1Galactoengineered immunoglobulin 1 antibodiesHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 1333US2016102298A1N-terminally truncated glycosyltransferasesROCHE DIAGNOSTICS OPERATIONS·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →